P2.31. Clinical Outcomes of Real-World Treatment for Metastatic EGFRm NSCLC after Osimertinib and Platinum-Based Chemotherapy - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Jyoti Patel
Meta Tag
Speaker Jyoti Patel
Topic Global Health, Health Services & Health Economics: Real World Data
clinical outcomes
metastatic EGFRm NSCLC
platinum-based chemotherapy
real-world treatment
propensity score weighting
overall survival
progression-free survival
objective response rate
Powered By